1 Market Overview

1.1 Product Overview and Scope of Biosimilar of Remicade

1.2 Classification of Biosimilar of Remicade by Type

1.2.1 Overview: Global Biosimilar of Remicade Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Biosimilar of Remicade Revenue Market Share by Type in 2021

1.2.3 Monoclonal Antibodies

1.2.4 Interferon

1.2.5 Erythropoietin

1.2.6 Insulin

1.2.7 Vaccines

1.2.8 Other

1.3 Global Biosimilar of Remicade Market by Application

1.3.1 Overview: Global Biosimilar of Remicade Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Tumor

1.3.3 Diabetes

1.3.4 Cardiovascular

1.3.5 Hemophilia

1.3.6 Other

1.4 Global Biosimilar of Remicade Market Size & Forecast

1.5 Global Biosimilar of Remicade Market Size and Forecast by Region

1.5.1 Global Biosimilar of Remicade Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Biosimilar of Remicade Market Size by Region, (2017-2022)

1.5.3 North America Biosimilar of Remicade Market Size and Prospect (2017-2028)

1.5.4 Europe Biosimilar of Remicade Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Biosimilar of Remicade Market Size and Prospect (2017-2028)

1.5.6 South America Biosimilar of Remicade Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Biosimilar of Remicade Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Biosimilar of Remicade Market Drivers

1.6.2 Biosimilar of Remicade Market Restraints

1.6.3 Biosimilar of Remicade Trends Analysis

2 Company Profiles

2.1 Roche

2.1.1 Roche Details

2.1.2 Roche Major Business

2.1.3 Roche Biosimilar of Remicade Product and Solutions

2.1.4 Roche Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Roche Recent Developments and Future Plans

2.2 Amgen

2.2.1 Amgen Details

2.2.2 Amgen Major Business

2.2.3 Amgen Biosimilar of Remicade Product and Solutions

2.2.4 Amgen Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Amgen Recent Developments and Future Plans

2.3 AbbVie

2.3.1 AbbVie Details

2.3.2 AbbVie Major Business

2.3.3 AbbVie Biosimilar of Remicade Product and Solutions

2.3.4 AbbVie Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 AbbVie Recent Developments and Future Plans

2.4 Sanofi-Aventis

2.4.1 Sanofi-Aventis Details

2.4.2 Sanofi-Aventis Major Business

2.4.3 Sanofi-Aventis Biosimilar of Remicade Product and Solutions

2.4.4 Sanofi-Aventis Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Sanofi-Aventis Recent Developments and Future Plans

2.5 Johnson & Johnson

2.5.1 Johnson & Johnson Details

2.5.2 Johnson & Johnson Major Business

2.5.3 Johnson & Johnson Biosimilar of Remicade Product and Solutions

2.5.4 Johnson & Johnson Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Johnson & Johnson Recent Developments and Future Plans

2.6 Pfizer

2.6.1 Pfizer Details

2.6.2 Pfizer Major Business

2.6.3 Pfizer Biosimilar of Remicade Product and Solutions

2.6.4 Pfizer Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Pfizer Recent Developments and Future Plans

2.7 Novo Nordisk

2.7.1 Novo Nordisk Details

2.7.2 Novo Nordisk Major Business

2.7.3 Novo Nordisk Biosimilar of Remicade Product and Solutions

2.7.4 Novo Nordisk Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Novo Nordisk Recent Developments and Future Plans

2.8 Eli Lilly

2.8.1 Eli Lilly Details

2.8.2 Eli Lilly Major Business

2.8.3 Eli Lilly Biosimilar of Remicade Product and Solutions

2.8.4 Eli Lilly Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Eli Lilly Recent Developments and Future Plans

2.9 Novartis

2.9.1 Novartis Details

2.9.2 Novartis Major Business

2.9.3 Novartis Biosimilar of Remicade Product and Solutions

2.9.4 Novartis Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Novartis Recent Developments and Future Plans

2.10 Merck

2.10.1 Merck Details

2.10.2 Merck Major Business

2.10.3 Merck Biosimilar of Remicade Product and Solutions

2.10.4 Merck Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Merck Recent Developments and Future Plans

2.11 3sbio

2.11.1 3sbio Details

2.11.2 3sbio Major Business

2.11.3 3sbio Biosimilar of Remicade Product and Solutions

2.11.4 3sbio Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 3sbio Recent Developments and Future Plans

2.12 Changchun High Tech

2.12.1 Changchun High Tech Details

2.12.2 Changchun High Tech Major Business

2.12.3 Changchun High Tech Biosimilar of Remicade Product and Solutions

2.12.4 Changchun High Tech Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Changchun High Tech Recent Developments and Future Plans

2.13 CP Guojian

2.13.1 CP Guojian Details

2.13.2 CP Guojian Major Business

2.13.3 CP Guojian Biosimilar of Remicade Product and Solutions

2.13.4 CP Guojian Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 CP Guojian Recent Developments and Future Plans

2.14 Biotech

2.14.1 Biotech Details

2.14.2 Biotech Major Business

2.14.3 Biotech Biosimilar of Remicade Product and Solutions

2.14.4 Biotech Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Biotech Recent Developments and Future Plans

2.15 Gelgen

2.15.1 Gelgen Details

2.15.2 Gelgen Major Business

2.15.3 Gelgen Biosimilar of Remicade Product and Solutions

2.15.4 Gelgen Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Gelgen Recent Developments and Future Plans

2.16 Innovent

2.16.1 Innovent Details

2.16.2 Innovent Major Business

2.16.3 Innovent Biosimilar of Remicade Product and Solutions

2.16.4 Innovent Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Innovent Recent Developments and Future Plans

2.17 Dong Bao

2.17.1 Dong Bao Details

2.17.2 Dong Bao Major Business

2.17.3 Dong Bao Biosimilar of Remicade Product and Solutions

2.17.4 Dong Bao Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Dong Bao Recent Developments and Future Plans

2.18 Ganlee

2.18.1 Ganlee Details

2.18.2 Ganlee Major Business

2.18.3 Ganlee Biosimilar of Remicade Product and Solutions

2.18.4 Ganlee Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Ganlee Recent Developments and Future Plans

2.19 United Laboratories

2.19.1 United Laboratories Details

2.19.2 United Laboratories Major Business

2.19.3 United Laboratories Biosimilar of Remicade Product and Solutions

2.19.4 United Laboratories Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 United Laboratories Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Biosimilar of Remicade Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Biosimilar of Remicade Players Market Share in 2021

3.2.2 Top 10 Biosimilar of Remicade Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Biosimilar of Remicade Players Head Office, Products and Services Provided

3.4 Biosimilar of Remicade Mergers & Acquisitions

3.5 Biosimilar of Remicade New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Biosimilar of Remicade Revenue and Market Share by Type (2017-2022)

4.2 Global Biosimilar of Remicade Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Biosimilar of Remicade Revenue Market Share by Application (2017-2022)

5.2 Global Biosimilar of Remicade Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Biosimilar of Remicade Revenue by Type (2017-2028)

6.2 North America Biosimilar of Remicade Revenue by Application (2017-2028)

6.3 North America Biosimilar of Remicade Market Size by Country

6.3.1 North America Biosimilar of Remicade Revenue by Country (2017-2028)

6.3.2 United States Biosimilar of Remicade Market Size and Forecast (2017-2028)

6.3.3 Canada Biosimilar of Remicade Market Size and Forecast (2017-2028)

6.3.4 Mexico Biosimilar of Remicade Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Biosimilar of Remicade Revenue by Type (2017-2028)

7.2 Europe Biosimilar of Remicade Revenue by Application (2017-2028)

7.3 Europe Biosimilar of Remicade Market Size by Country

7.3.1 Europe Biosimilar of Remicade Revenue by Country (2017-2028)

7.3.2 Germany Biosimilar of Remicade Market Size and Forecast (2017-2028)

7.3.3 France Biosimilar of Remicade Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Biosimilar of Remicade Market Size and Forecast (2017-2028)

7.3.5 Russia Biosimilar of Remicade Market Size and Forecast (2017-2028)

7.3.6 Italy Biosimilar of Remicade Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Biosimilar of Remicade Revenue by Type (2017-2028)

8.2 Asia-Pacific Biosimilar of Remicade Revenue by Application (2017-2028)

8.3 Asia-Pacific Biosimilar of Remicade Market Size by Region

8.3.1 Asia-Pacific Biosimilar of Remicade Revenue by Region (2017-2028)

8.3.2 China Biosimilar of Remicade Market Size and Forecast (2017-2028)

8.3.3 Japan Biosimilar of Remicade Market Size and Forecast (2017-2028)

8.3.4 South Korea Biosimilar of Remicade Market Size and Forecast (2017-2028)

8.3.5 India Biosimilar of Remicade Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Biosimilar of Remicade Market Size and Forecast (2017-2028)

8.3.7 Australia Biosimilar of Remicade Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Biosimilar of Remicade Revenue by Type (2017-2028)

9.2 South America Biosimilar of Remicade Revenue by Application (2017-2028)

9.3 South America Biosimilar of Remicade Market Size by Country

9.3.1 South America Biosimilar of Remicade Revenue by Country (2017-2028)

9.3.2 Brazil Biosimilar of Remicade Market Size and Forecast (2017-2028)

9.3.3 Argentina Biosimilar of Remicade Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Biosimilar of Remicade Revenue by Type (2017-2028)

10.2 Middle East & Africa Biosimilar of Remicade Revenue by Application (2017-2028)

10.3 Middle East & Africa Biosimilar of Remicade Market Size by Country

10.3.1 Middle East & Africa Biosimilar of Remicade Revenue by Country (2017-2028)

10.3.2 Turkey Biosimilar of Remicade Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Biosimilar of Remicade Market Size and Forecast (2017-2028)

10.3.4 UAE Biosimilar of Remicade Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Biosimilar of Remicade Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Biosimilar of Remicade Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Biosimilar of Remicade Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Biosimilar of Remicade Revenue (USD Million) by Region (2017-2022)

Table 5. Global Biosimilar of Remicade Revenue Market Share by Region (2023-2028)

Table 6. Roche Corporate Information, Head Office, and Major Competitors

Table 7. Roche Major Business

Table 8. Roche Biosimilar of Remicade Product and Solutions

Table 9. Roche Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Amgen Corporate Information, Head Office, and Major Competitors

Table 11. Amgen Major Business

Table 12. Amgen Biosimilar of Remicade Product and Solutions

Table 13. Amgen Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. AbbVie Corporate Information, Head Office, and Major Competitors

Table 15. AbbVie Major Business

Table 16. AbbVie Biosimilar of Remicade Product and Solutions

Table 17. AbbVie Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Sanofi-Aventis Corporate Information, Head Office, and Major Competitors

Table 19. Sanofi-Aventis Major Business

Table 20. Sanofi-Aventis Biosimilar of Remicade Product and Solutions

Table 21. Sanofi-Aventis Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 23. Johnson & Johnson Major Business

Table 24. Johnson & Johnson Biosimilar of Remicade Product and Solutions

Table 25. Johnson & Johnson Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Pfizer Corporate Information, Head Office, and Major Competitors

Table 27. Pfizer Major Business

Table 28. Pfizer Biosimilar of Remicade Product and Solutions

Table 29. Pfizer Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Novo Nordisk Corporate Information, Head Office, and Major Competitors

Table 31. Novo Nordisk Major Business

Table 32. Novo Nordisk Biosimilar of Remicade Product and Solutions

Table 33. Novo Nordisk Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 35. Eli Lilly Major Business

Table 36. Eli Lilly Biosimilar of Remicade Product and Solutions

Table 37. Eli Lilly Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Novartis Corporate Information, Head Office, and Major Competitors

Table 39. Novartis Major Business

Table 40. Novartis Biosimilar of Remicade Product and Solutions

Table 41. Novartis Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Merck Corporate Information, Head Office, and Major Competitors

Table 43. Merck Major Business

Table 44. Merck Biosimilar of Remicade Product and Solutions

Table 45. Merck Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. 3sbio Corporate Information, Head Office, and Major Competitors

Table 47. 3sbio Major Business

Table 48. 3sbio Biosimilar of Remicade Product and Solutions

Table 49. 3sbio Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Changchun High Tech Corporate Information, Head Office, and Major Competitors

Table 51. Changchun High Tech Major Business

Table 52. Changchun High Tech Biosimilar of Remicade Product and Solutions

Table 53. Changchun High Tech Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. CP Guojian Corporate Information, Head Office, and Major Competitors

Table 55. CP Guojian Major Business

Table 56. CP Guojian Biosimilar of Remicade Product and Solutions

Table 57. CP Guojian Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Biotech Corporate Information, Head Office, and Major Competitors

Table 59. Biotech Major Business

Table 60. Biotech Biosimilar of Remicade Product and Solutions

Table 61. Biotech Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Gelgen Corporate Information, Head Office, and Major Competitors

Table 63. Gelgen Major Business

Table 64. Gelgen Biosimilar of Remicade Product and Solutions

Table 65. Gelgen Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Innovent Corporate Information, Head Office, and Major Competitors

Table 67. Innovent Major Business

Table 68. Innovent Biosimilar of Remicade Product and Solutions

Table 69. Innovent Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Dong Bao Corporate Information, Head Office, and Major Competitors

Table 71. Dong Bao Major Business

Table 72. Dong Bao Biosimilar of Remicade Product and Solutions

Table 73. Dong Bao Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Ganlee Corporate Information, Head Office, and Major Competitors

Table 75. Ganlee Major Business

Table 76. Ganlee Biosimilar of Remicade Product and Solutions

Table 77. Ganlee Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. United Laboratories Corporate Information, Head Office, and Major Competitors

Table 79. United Laboratories Major Business

Table 80. United Laboratories Biosimilar of Remicade Product and Solutions

Table 81. United Laboratories Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. Global Biosimilar of Remicade Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 83. Global Biosimilar of Remicade Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 84. Breakdown of Biosimilar of Remicade by Company Type (Tier 1, Tier 2 and Tier 3)

Table 85. Biosimilar of Remicade Players Head Office, Products and Services Provided

Table 86. Biosimilar of Remicade Mergers & Acquisitions in the Past Five Years

Table 87. Biosimilar of Remicade New Entrants and Expansion Plans

Table 88. Global Biosimilar of Remicade Revenue (USD Million) by Type (2017-2022)

Table 89. Global Biosimilar of Remicade Revenue Share by Type (2017-2022)

Table 90. Global Biosimilar of Remicade Revenue Forecast by Type (2023-2028)

Table 91. Global Biosimilar of Remicade Revenue by Application (2017-2022)

Table 92. Global Biosimilar of Remicade Revenue Forecast by Application (2023-2028)

Table 93. North America Biosimilar of Remicade Revenue by Type (2017-2022) & (USD Million)

Table 94. North America Biosimilar of Remicade Revenue by Type (2023-2028) & (USD Million)

Table 95. North America Biosimilar of Remicade Revenue by Application (2017-2022) & (USD Million)

Table 96. North America Biosimilar of Remicade Revenue by Application (2023-2028) & (USD Million)

Table 97. North America Biosimilar of Remicade Revenue by Country (2017-2022) & (USD Million)

Table 98. North America Biosimilar of Remicade Revenue by Country (2023-2028) & (USD Million)

Table 99. Europe Biosimilar of Remicade Revenue by Type (2017-2022) & (USD Million)

Table 100. Europe Biosimilar of Remicade Revenue by Type (2023-2028) & (USD Million)

Table 101. Europe Biosimilar of Remicade Revenue by Application (2017-2022) & (USD Million)

Table 102. Europe Biosimilar of Remicade Revenue by Application (2023-2028) & (USD Million)

Table 103. Europe Biosimilar of Remicade Revenue by Country (2017-2022) & (USD Million)

Table 104. Europe Biosimilar of Remicade Revenue by Country (2023-2028) & (USD Million)

Table 105. Asia-Pacific Biosimilar of Remicade Revenue by Type (2017-2022) & (USD Million)

Table 106. Asia-Pacific Biosimilar of Remicade Revenue by Type (2023-2028) & (USD Million)

Table 107. Asia-Pacific Biosimilar of Remicade Revenue by Application (2017-2022) & (USD Million)

Table 108. Asia-Pacific Biosimilar of Remicade Revenue by Application (2023-2028) & (USD Million)

Table 109. Asia-Pacific Biosimilar of Remicade Revenue by Region (2017-2022) & (USD Million)

Table 110. Asia-Pacific Biosimilar of Remicade Revenue by Region (2023-2028) & (USD Million)

Table 111. South America Biosimilar of Remicade Revenue by Type (2017-2022) & (USD Million)

Table 112. South America Biosimilar of Remicade Revenue by Type (2023-2028) & (USD Million)

Table 113. South America Biosimilar of Remicade Revenue by Application (2017-2022) & (USD Million)

Table 114. South America Biosimilar of Remicade Revenue by Application (2023-2028) & (USD Million)

Table 115. South America Biosimilar of Remicade Revenue by Country (2017-2022) & (USD Million)

Table 116. South America Biosimilar of Remicade Revenue by Country (2023-2028) & (USD Million)

Table 117. Middle East & Africa Biosimilar of Remicade Revenue by Type (2017-2022) & (USD Million)

Table 118. Middle East & Africa Biosimilar of Remicade Revenue by Type (2023-2028) & (USD Million)

Table 119. Middle East & Africa Biosimilar of Remicade Revenue by Application (2017-2022) & (USD Million)

Table 120. Middle East & Africa Biosimilar of Remicade Revenue by Application (2023-2028) & (USD Million)

Table 121. Middle East & Africa Biosimilar of Remicade Revenue by Country (2017-2022) & (USD Million)

Table 122. Middle East & Africa Biosimilar of Remicade Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Biosimilar of Remicade Picture

Figure 2. Global Biosimilar of Remicade Revenue Market Share by Type in 2021

Figure 3. Monoclonal Antibodies

Figure 4. Interferon

Figure 5. Erythropoietin

Figure 6. Insulin

Figure 7. Vaccines

Figure 8. Other

Figure 9. Biosimilar of Remicade Revenue Market Share by Application in 2021

Figure 10. Tumor Picture

Figure 11. Diabetes Picture

Figure 12. Cardiovascular Picture

Figure 13. Hemophilia Picture

Figure 14. Other Picture

Figure 15. Global Biosimilar of Remicade Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 16. Global Biosimilar of Remicade Revenue and Forecast (2017-2028) & (USD Million)

Figure 17. Global Biosimilar of Remicade Revenue Market Share by Region (2017-2028)

Figure 18. Global Biosimilar of Remicade Revenue Market Share by Region in 2021

Figure 19. North America Biosimilar of Remicade Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Europe Biosimilar of Remicade Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Asia-Pacific Biosimilar of Remicade Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. South America Biosimilar of Remicade Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. Middle East and Africa Biosimilar of Remicade Revenue (USD Million) and Growth Rate (2017-2028)

Figure 24. Biosimilar of Remicade Market Drivers

Figure 25. Biosimilar of Remicade Market Restraints

Figure 26. Biosimilar of Remicade Market Trends

Figure 27. Roche Recent Developments and Future Plans

Figure 28. Amgen Recent Developments and Future Plans

Figure 29. AbbVie Recent Developments and Future Plans

Figure 30. Sanofi-Aventis Recent Developments and Future Plans

Figure 31. Johnson & Johnson Recent Developments and Future Plans

Figure 32. Pfizer Recent Developments and Future Plans

Figure 33. Novo Nordisk Recent Developments and Future Plans

Figure 34. Eli Lilly Recent Developments and Future Plans

Figure 35. Novartis Recent Developments and Future Plans

Figure 36. Merck Recent Developments and Future Plans

Figure 37. 3sbio Recent Developments and Future Plans

Figure 38. Changchun High Tech Recent Developments and Future Plans

Figure 39. CP Guojian Recent Developments and Future Plans

Figure 40. Biotech Recent Developments and Future Plans

Figure 41. Gelgen Recent Developments and Future Plans

Figure 42. Innovent Recent Developments and Future Plans

Figure 43. Dong Bao Recent Developments and Future Plans

Figure 44. Ganlee Recent Developments and Future Plans

Figure 45. United Laboratories Recent Developments and Future Plans

Figure 46. Global Biosimilar of Remicade Revenue Share by Players in 2021

Figure 47. Biosimilar of Remicade Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 48. Global Top 3 Players Biosimilar of Remicade Revenue Market Share in 2021

Figure 49. Global Top 10 Players Biosimilar of Remicade Revenue Market Share in 2021

Figure 50. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 51. Global Biosimilar of Remicade Revenue Share by Type in 2021

Figure 52. Global Biosimilar of Remicade Market Share Forecast by Type (2023-2028)

Figure 53. Global Biosimilar of Remicade Revenue Share by Application in 2021

Figure 54. Global Biosimilar of Remicade Market Share Forecast by Application (2023-2028)

Figure 55. North America Biosimilar of Remicade Sales Market Share by Type (2017-2028)

Figure 56. North America Biosimilar of Remicade Sales Market Share by Application (2017-2028)

Figure 57. North America Biosimilar of Remicade Revenue Market Share by Country (2017-2028)

Figure 58. United States Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Canada Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Mexico Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Europe Biosimilar of Remicade Sales Market Share by Type (2017-2028)

Figure 62. Europe Biosimilar of Remicade Sales Market Share by Application (2017-2028)

Figure 63. Europe Biosimilar of Remicade Revenue Market Share by Country (2017-2028)

Figure 64. Germany Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. France Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. United Kingdom Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Russia Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Italy Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Asia-Pacific Biosimilar of Remicade Sales Market Share by Type (2017-2028)

Figure 70. Asia-Pacific Biosimilar of Remicade Sales Market Share by Application (2017-2028)

Figure 71. Asia-Pacific Biosimilar of Remicade Revenue Market Share by Region (2017-2028)

Figure 72. China Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Japan Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. South Korea Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. India Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Southeast Asia Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Australia Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. South America Biosimilar of Remicade Sales Market Share by Type (2017-2028)

Figure 79. South America Biosimilar of Remicade Sales Market Share by Application (2017-2028)

Figure 80. South America Biosimilar of Remicade Revenue Market Share by Country (2017-2028)

Figure 81. Brazil Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Argentina Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. Middle East and Africa Biosimilar of Remicade Sales Market Share by Type (2017-2028)

Figure 84. Middle East and Africa Biosimilar of Remicade Sales Market Share by Application (2017-2028)

Figure 85. Middle East and Africa Biosimilar of Remicade Revenue Market Share by Country (2017-2028)

Figure 86. Turkey Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 87. Saudi Arabia Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 88. UAE Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 89. Methodology

Figure 90. Research Process and Data Source